AAAAAA

   
Results: 1-17 |
Results: 17
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin
Authors: Laurie, SA Pfister, DG Kris, MG Tong, WP Chronowski, G Pisters, KWM Heelan, RT Sirotnak, FM
Citation: Sa. Laurie et al., Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin, CLIN CANC R, 7(3), 2001, pp. 501-509
A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: Where does it fit among available treatment options?
Authors: Pfister, DG Sherman, EJ Wolden, SL
Citation: Dg. Pfister et al., A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: Where does it fit among available treatment options?, CANCER INV, 19(2), 2001, pp. 217-218
Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology
Authors: Recht, A Edge, SB Solin, LJ Robinson, DS Estabrook, A Fine, RE Fleming, GF Formenti, S Hudis, C Kirshner, JJ Krause, DA Kuske, RR Langer, AS Sledge, GW Whelan, TJ Pfister, DG
Citation: A. Recht et al., Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology, J CL ONCOL, 19(5), 2001, pp. 1539-1569
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma
Authors: Wolden, SL Zelefsky, MJ Kraus, DH Rosenzweig, KE Chong, LM Shaha, AR Zhang, H Harrison, LB Shah, JP Pfister, DG
Citation: Sl. Wolden et al., Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma, J CL ONCOL, 19(4), 2001, pp. 1105-1110
Failure of a 3D conformal boost to improve radiotherapy for nasopharyngealcarcinoma
Authors: Wolden, SL Zelefsky, MJ Hunt, MA Rosenzweig, KE Chong, LM Kraus, DH Pfister, DG Leibel, SA
Citation: Sl. Wolden et al., Failure of a 3D conformal boost to improve radiotherapy for nasopharyngealcarcinoma, INT J RAD O, 49(5), 2001, pp. 1229-1234
The collection of indirect and nonmedical direct costs (COIN) form - A newtool for collecting the invisible costs of androgen independent prostate carcinoma
Authors: Sherman, EJ Pfister, DG Ruchlin, HS Rubin, DM Radzyner, MH Kelleher, GH Slovin, SF Kelly, WK Scher, HI
Citation: Ej. Sherman et al., The collection of indirect and nonmedical direct costs (COIN) form - A newtool for collecting the invisible costs of androgen independent prostate carcinoma, CANCER, 91(4), 2001, pp. 841-853
Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550)
Authors: Soignet, SL Miller, VA Pfister, DG Bienvenu, BJ Ho, R Parker, BA Amyotte, SA Cato, A Warrell, RP
Citation: Sl. Soignet et al., Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550), CLIN CANC R, 6(5), 2000, pp. 1731-1735
NCCN Practice Guidelines for head and neck cancers
Authors: Forastiere, AA Pfister, DG Ang, K Brockstein, B Colevas, AD Ellenhorn, J Goepfert, H Hicks, WL Hong, WK Kies, MS Lydiatt, W McCaffrey, T Mittal, BB Ridge, JA Schuller, DE Shah, JP Spencer, S Trotti, A Urba, S Weymuller, EA Wheeler, RH Wolf, GT
Citation: Aa. Forastiere et al., NCCN Practice Guidelines for head and neck cancers, ONCOLOGY-NY, 14(11A), 2000, pp. 163-194
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer
Authors: Hillner, BE Ingle, JN Berenson, JR Janjan, NA Albain, KS Lipton, A Yee, G Biermann, JS Chlebowski, RT Pfister, DG
Citation: Be. Hillner et al., American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer, J CL ONCOL, 18(6), 2000, pp. 1378-1391
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines
Authors: Benson, AB Desch, CE Flynn, PJ Krause, C Loprinzi, CL Minsky, BD Petrelli, NJ Pfister, DG Smith, TJ Somerfield, MR
Citation: Ab. Benson et al., 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines, J CL ONCOL, 18(20), 2000, pp. 3586-3588
Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer
Authors: Wolden, SL Steinherz, PG Kraus, DH Zelefsky, MJ Pfister, DG Wollner, N
Citation: Sl. Wolden et al., Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer, INT J RAD O, 46(4), 2000, pp. 859-864
Clinical economics of head and neck malignancies
Authors: Sherman, EJ Ruchlin, HS Holden, JS Pfister, DG
Citation: Ej. Sherman et al., Clinical economics of head and neck malignancies, HEMAT ONCOL, 13(4), 1999, pp. 867
Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines
Authors: Gralla, RJ Osoba, D Kris, MG Kirkbride, P Hesketh, PJ Chinnery, LW Clark-Snow, R Gill, DP Groshen, S Grunberg, S Koeller, JM Morrow, GR Perez, EA Silber, JH Pfister, DG
Citation: Rj. Gralla et al., Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines, J CL ONCOL, 17(9), 1999, pp. 2971-2994
American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: Tamoxifen and raloxifene
Authors: Chlebowski, RT Collyar, DE Somerfield, MR Pfister, DG
Citation: Rt. Chlebowski et al., American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: Tamoxifen and raloxifene, J CL ONCOL, 17(6), 1999, pp. 1939-1955
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology
Authors: Desch, CE Benson, AB Smith, TJ Flynn, PJ Krause, C Loprinzi, CL Minsky, BD Petrelli, NJ Pfister, DG Somerfield, MR
Citation: Ce. Desch et al., Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology, J CL ONCOL, 17(4), 1999, pp. 1312-1321
American Society of Clinical Oncology clinical practice guidelines for theuse of chemotherapy and radiotherapy protectants
Authors: Hensley, ML Schuchter, LM Lindley, C Meropol, NJ Cohen, GI Broder, G Gradishar, WJ Green, DM Langdon, RJ Mitchell, B Negrin, R Szatrowski, TP Thigpen, JT Von Hoff, D Wasserman, TH Winer, EP Pfister, DG
Citation: Ml. Hensley et al., American Society of Clinical Oncology clinical practice guidelines for theuse of chemotherapy and radiotherapy protectants, J CL ONCOL, 17(10), 1999, pp. 3333-3355
Factors associated with complications in microvascular reconstruction of head and neck defects
Authors: Singh, B Cordeiro, PG Santamaria, E Shaha, AR Pfister, DG Shah, JP
Citation: B. Singh et al., Factors associated with complications in microvascular reconstruction of head and neck defects, PLAS R SURG, 103(2), 1999, pp. 403-411
Risultati: 1-17 |